Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Table of Contents.
Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology.
The Costimulatory Receptor OX40 Inhibits Interleukin-17 Expression through Activation of Repressive Chromatin Remodeling Pathways.
Antibodies to the RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein A1 Colocalize to Stress Granules Resulting in Altered RNA and Protein Levels in a Model of Neurodegeneration in Multiple Sclerosis.
A Minimally-invasive Blood-derived Biomarker of Oligodendrocyte Cell-loss in Multiple Sclerosis.
The Experience of Men Caring for a Partner With Multiple Sclerosis.
Pharmacogenomic study in patients with multiple sclerosis: Responders and nonresponders to IFN-β.
Enantioselective analysis of 4-hydroxycyclophosphamide in human plasma with application to a clinical pharmacokinetic study.
Dilated perivascular spaces and fatigue: is there a link? Magnetic resonance retrospective 3Tesla study.
LPS-matured CD11c+ bone marrow-derived dendritic cells can initiate autoimmune pathology with minimal injection site inflammation.
Perspiration Functions in Different Ethnic, Age, and Sex Populations: Modification of Sudomotor Function.
Patients smoking cannabis are risking their health.
Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray.
Liver X receptors: from cholesterol regulation to neuroprotection-a new barrier against neurodegeneration in amyotrophic lateral sclerosis?
STARs in the CNS.
Progranulin: A key player in autoimmune diseases.
Clinical insights for early detection of acute transverse myelitis in the emergency department.
Progression of motor axon dysfunction and ectopic Nav1.8 expression in a mouse model of Charcot-Marie-Tooth disease 1B.
Pancolitis a novel early complication of Alemtuzumab for MS treatment.
Lesson of the month 1: Post-malaria neurological syndromes.
Molecular diagnostics of neurodegenerative disorders.
[Melatonin as an inducing factor for multiple sclerosis].
Marchiafava-Bignami disease in chronic alcoholic patient.
The association of other autoimmune diseases in patients with autoimmune thyroiditis: Review of the literature and report of a large series of patients.
Anti-inflammatory activity of Barleria lupulina: Identification of active compounds that activate the Nrf2 cell defense pathway, organize cortical actin, reduce stress fibers, and improve cell junctions in microvascular endothelial cells.
Pages
« first
‹ previous
…
791
792
793
794
795
796
797
798
799
…
next ›
last »